ClinicalTrials.Veeva

Menu

Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root

Galderma logo

Galderma

Status

Completed

Conditions

Nasal Augmentation

Treatments

Device: Restylane Perlane

Study type

Interventional

Funder types

Industry

Identifiers

NCT02216851
43CH1310

Details and patient eligibility

About

The purpose of this study is to determine the safety and efficacy of using Restylane Perlane to shape the nasal dorsum and/or nasal root in comparison with a no-treatment control group

Enrollment

132 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chinese origin
  • Subject with desire to shape the nasal dorsum and/or nasal root
  • Subjects who, in the opinion of the investigator, can achieve a clinically meaningful aesthetic correction of their nose with ≤ 1 ml Restylane Perlane

Exclusion criteria

  • Subjects with previous nasal surgery, including grafts or implants to the nose area
  • Subjects requiring filler treatment around the tip of the nose or between the eyebrows (glabella region) to achieve a good aesthetic outcome
  • Subjects with a history of chronic sinusitis or rhinitis
  • Subjects who have previously received aesthetic treatment in the forehead, glabellar and/or nose area with a dermal filler

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

132 participants in 2 patient groups

Restylane Perlane
Experimental group
Description:
Single injection of Restylane Perlane in nasal dorsum and/or nasal root
Treatment:
Device: Restylane Perlane
No-treatment control
No Intervention group
Description:
No-treatment control group do not receive any treatment during the main study period

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems